Using the Flory−Huggins parameter and a previously measured value of the Maier−Saupe parameter, the PPV-b-PI phase diagram may be converted from system-specific variables to dimensionless parameters.

The ionic partition diagram methodology has been generalized to address both hydrophilic and lipophilic compounds and to consider biphasic systems with variable phase volume ratios. With this ...

This package lets you generate entity relation diagrams by inspecting the relationships defined in your model files. It is highly customizable. Behind the scenes, it uses GraphViz to generate the ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

Otsuka Pharmaceuticals’ investigational antibody sibeprenlimab significantly lowered urinary protein levels in patients with immunoglobulin A nephropathy in a Phase III trial, the company reported ...

SSC Selection Post Phase 13 Online Form is released for 2423 vacancies at ssc.gov.in. The deadline to apply online is 23 June. Find the direct SSC Phase 13 Apply Online Link, fees, dates and other ...

ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC). This ...

Southern California’s air quality regulators are set to vote this week on new rules aimed at phasing out the sale of gas-powered furnaces and water heaters in the region.

Moonlake is running phase 3 studies of the nanobody in psoriatic arthritis and advancing the drug candidate toward pivotal trials in psoriasis, palmoplantar pustulosis and axial spondyloarthritis.

The Staff Selection Commission (SSC) announced the Selection Post Phase 13 Notification on Monday, June 2, 2025, for eligible candidates who have passed Class 10 and 12, and for those who hold ...

The KT-621 Phase Ib trial in moderate and severe AD is actively recruiting with data expected in Q4 of 2025. Additionally, two parallel Phase IIb trials in AD and asthma are planned to start in Q4 ...